28101466|t|Characterization of the Effect of Drug-Drug Interaction on Protein Binding in Concurrent Administration of Sulfamethoxazol and Diclofenac Sodium Using Bovine Serum Albumin
28101466|a|Purpose: This project was aimed to determine the effect of concurrent administration of sulfamethoxazole and diclofenac sodium. Methods: Equilibrium dialysis method was adopted to study different protein binding aspects of sulfamethoxazole and diclofenac sodium. Results: Sulfamethoxazole showed two types of association constants; high affinity constant 29.0±0.20×10(6) M(-1) with lower number of binding sites of 0.7±1 and low affinity constant 1.13±0.20×10(6) M(-1) with higher number of binding sites of 3.45±1 at pH 7.4 and 40 °C temperature. Diclofenac sodium showed high affinity constant 33.66±0.20×10(6) M(-1) with lower number of binding sites of 1.01±1 and low affinity constant 1.72±0.20×10(6) M(-1) with higher number of binding sites of 6.40±1 at the same condition. Site specific probe displacement data implied that site-I, warfarin sodium site, was the high affinity site, while site-II, diazepam site, was the low affinity site for these drugs. During concurrent administration, sulfamethoxazole increased the free concentration of diclofenac sodium from 17.5±0.14% to 70.0±0.014% in absence and from 22.5±0.07% to 83.0±0.014% in presence of site-I specific probe. Diclofenac sodium also increased the free concentration of sulfamethoxazole from 2.8±0.07% to 52.0±0.14% and from 8.5±0.014% to 64.4±0.07% in absence and presence of site-I specific probe respectively. Conclusion: The study revealed that the concurrent administration of sulfamethoxazole and diclofenac sodium may result drug concentration alteration in blood.
28101466	34	55	Drug-Drug Interaction	T038	UMLS:C0687133
28101466	59	74	Protein Binding	T038	UMLS:C0033618
28101466	89	103	Administration	T058	UMLS:C1533734
28101466	107	122	Sulfamethoxazol	T103	UMLS:C0038689
28101466	127	144	Diclofenac Sodium	T103	UMLS:C0700583
28101466	151	171	Bovine Serum Albumin	T103	UMLS:C0036774
28101466	242	256	administration	T058	UMLS:C1533734
28101466	260	276	sulfamethoxazole	T103	UMLS:C0038689
28101466	281	298	diclofenac sodium	T103	UMLS:C0700583
28101466	309	336	Equilibrium dialysis method	T058	UMLS:C0022885
28101466	352	357	study	T062	UMLS:C2603343
28101466	368	391	protein binding aspects	T038	UMLS:C0033618
28101466	395	411	sulfamethoxazole	T103	UMLS:C0038689
28101466	416	433	diclofenac sodium	T103	UMLS:C0700583
28101466	444	460	Sulfamethoxazole	T103	UMLS:C0038689
28101466	570	583	binding sites	T082	UMLS:C1514562
28101466	663	676	binding sites	T082	UMLS:C1514562
28101466	720	737	Diclofenac sodium	T103	UMLS:C0700583
28101466	812	825	binding sites	T082	UMLS:C1514562
28101466	906	919	binding sites	T082	UMLS:C1514562
28101466	1004	1010	site-I	T082	UMLS:C1514562
28101466	1012	1027	warfarin sodium	T103	UMLS:C0376218
28101466	1028	1032	site	T082	UMLS:C1514562
28101466	1042	1060	high affinity site	T082	UMLS:C1514562
28101466	1068	1075	site-II	T082	UMLS:C1514562
28101466	1077	1085	diazepam	T103	UMLS:C0012010
28101466	1086	1090	site	T082	UMLS:C1514562
28101466	1100	1117	low affinity site	T082	UMLS:C1514562
28101466	1128	1133	drugs	T103	UMLS:C1254351
28101466	1153	1167	administration	T058	UMLS:C1533734
28101466	1169	1185	sulfamethoxazole	T103	UMLS:C0038689
28101466	1222	1239	diclofenac sodium	T103	UMLS:C0700583
28101466	1320	1328	presence	T033	UMLS:C0150312
28101466	1332	1353	site-I specific probe	T103	UMLS:C0026381
28101466	1355	1372	Diclofenac sodium	T103	UMLS:C0700583
28101466	1414	1430	sulfamethoxazole	T103	UMLS:C0038689
28101466	1509	1517	presence	T033	UMLS:C0150312
28101466	1521	1542	site-I specific probe	T103	UMLS:C0026381
28101466	1573	1578	study	T062	UMLS:C2603343
28101466	1608	1622	administration	T058	UMLS:C1533734
28101466	1626	1642	sulfamethoxazole	T103	UMLS:C0038689
28101466	1647	1664	diclofenac sodium	T103	UMLS:C0700583
28101466	1709	1714	blood	T031	UMLS:C0005767